Articles from Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Carlyle Credit Income Fund (NYSE: CCIF) f/k/a Vertical Capital Income Fund (“Carlyle” or the “Company”) (NYSE: VCIF) on behalf of Carlyle stockholders. Our investigation concerns whether Carlyle has violated the federal securities laws and/or engaged in other unlawful business practices.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against VNET Group, Inc. (“VNET” or the “Company”) (NASDAQ: VNET) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired VNET securities between April 8, 2022 and February 15, 2023, both dates inclusive (the “Class Period”). Investors have until February 26, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Barclays securities between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”). Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired SolarEdge securities between February 22, 2022, and October 19, 2023, both dates inclusive (the “Class Period”). Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Outlook securities between August 3, 2021 and August 29, 2023, both dates inclusive (the “Class Period”). Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or the “Company”) (NASDAQ: BCLI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Brainstorm Cell securities between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”). Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DermTech, Inc. (NASDAQ: DMTK) on behalf of long-term stockholders following a class action complaint that was filed against DermTech on October 15, 2023 with a Class Period from May 3, 2022 to November 3, 2022. Our investigation concerns whether the board of directors of DermTech have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SunPower Corporation (NASDAQ: SPWR) on behalf of long-term stockholders following a class action complaint that was filed against SunPower on October 27, 2023 with a Class Period from March 9, 2023 to October 24, 2023. Our investigation concerns whether the board of directors of SunPower have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) on behalf of long-term stockholders following a class action complaint that was filed against AdaptHealth on October 24, 2023 with a Class Period from August 4, 2020 to February 27, 2023; and/or (ii) traceable to the Company’s secondary public offering conducted on or around January 5, 2021 (the “SPO”). Our investigation concerns whether the board of directors of AdaptHealth have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Grand Canyon Education, Inc. (NASDAQ: LOPE) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Grand Canyon have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP) on behalf of long-term stockholders following a class action complaint that was filed against Compass Minerals on October 21, 2022 with a Class Period from October 31, 2017 to November 18, 2018. Our investigation concerns whether the board of directors of Compass Minerals have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SentinelOne, Inc. (NYSE: S) on behalf of long-term stockholders following a class action complaint that was filed against SentinelOne on June 6, 2023 with a Class Period from June 1, 2022 to June 1, 2023. Our investigation concerns whether the board of directors of SentinelOne have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Unity Software, Inc. (NYSE: U) on behalf of long-term stockholders following a class action complaint that was filed against Unity on July 6, 2022 with a Class Period from March 5, 2021 to May 10, 2022. Our investigation concerns whether the board of directors of Unity have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inotiv, Inc. (NASDAQ: NOTV) on behalf of long-term stockholders following a class action complaint that was filed against Inotiv on June 23, 2022 with a Class Period from September 21, 2021 to November 16, 2022. Our investigation concerns whether the board of directors of Inotiv have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FibroGen, Inc. (NASDAQ: FGEN) on behalf of long-term stockholders following a class action complaint that was filed against FibroGen on April 12, 2021 with a Class Period from December 20, 2018 to July 15, 2021. Our investigation concerns whether the board of directors of FibroGen have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Bioventus Inc. (NASDAQ: BVS) on behalf of long-term stockholders following a class action complaint that was filed against Bioventus on January 12, 2023 with a Class Period Pursuant to the February 11, 2021 IPO. Our investigation concerns whether the board of directors of Bioventus have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Torrid Holdings, Inc. (NYSE: CURV) on behalf of long-term stockholders following a class action complaint that was filed against Torrid on November 16, 2022 with a Class Period pursuant to the company's July 2021 IPO. Our investigation concerns whether the board of directors of Torrid have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Amtech Systems, Inc. (“Amtech” or the “Company”) (NASDAQ: ASYS) on behalf of Amtech stockholders. Our investigation concerns whether Amtech has violated the federal securities laws and/or engaged in other unlawful business practices.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) in the United States District Court for the District of Minnesota on behalf of all persons and entities who purchased or otherwise acquired Inspire Medical common stock between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”). Investors have until February 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Natera, Inc. (NASDAQ: NTRA) on behalf of long-term stockholders following a class action complaint that was filed against Natera on March 10, 2022 with a Class Period from February 26, 2020 to April 19, 2022. Our investigation concerns whether the board of directors of Natera have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allbirds, Inc. (NASDAQ: BIRD) on behalf of long-term stockholders following a class action complaint that was filed against Allbirds on April 13, 2023 with a Class Period in connection with the Company’s November 2021 IPO and/or from November 4, 2021 to March 9, 2023. Our investigation concerns whether the board of directors of Allbirds have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Driven Brands Holdings, Inc. (“Driven” or the “Company”) (NASDAQ: DRVN) in the United States District Court for the Western District of North Carolina on behalf of all persons and entities who purchased or otherwise acquired Driven common stock between October 27, 2021, and August 1, 2023, both dates inclusive (the “Class Period”). Investors have until February 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Live Nation Entertainment, Inc. (NYSE: LYV) on behalf of long-term stockholders following a class action complaint that was filed against Live Nation on August 4, 2023 with a Class Period from February 23, 2022 to July 28, 2023. Our investigation concerns whether the board of directors of Live Nation have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Envoy Medical, Inc. (“Envoy” or the “Company”) (NASDAQ: COCH) on behalf of Envoy stockholders. Our investigation concerns whether Envoy has violated the federal securities laws and/or engaged in other unlawful business practices.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Brooge Energy Limited (“Brooge” or the “Company”) (NASDAQ: BROG) on behalf of Brooge stockholders. Our investigation concerns whether Brooge has violated the federal securities laws and/or engaged in other unlawful business practices.